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Background: The traditional definition of contrast induced nephropathy (CIN) has been an absolute rise of serum creatinine (Cr) of ≥0.5 mg/dL 
although most recent clinical trials have used a ≥25% increase from baseline Cr. The clinical implication of this definition change remains unknown.
Methods: We compared the association of the two definitions with risk of death or need for dialysis among 58,957 patients undergoing 
percutaneous coronary intervention during 2007-2008 in a large collaborative registry. Patients already on hemodialysis were excluded.
Results: CIN as defined by a rise in Cr ≥0.5 mg/dL (traditional CIN) developed in 1,601 while CIN defined as ≥25% increase in baseline Cr (new 
CIN) developed in 4,308 patients. CIN (traditional) was more commonly seen in patients with abnormal renal function compared with CIN (new) 
which was more likely to develop in patients with normal renal function at baseline. Patients developing CIN (traditional) were more likely to die and 
require in-hospital dialysis while those who did not experience a rise of Cr ≥0.5 mg/dL but did have a Cr ≥25% from baseline had a good outcome.
Conclusions: Our data suggests that the traditional definition of CIN (a rise in Cr of ≥0.5 mg/dL) in patients undergoing 
PCI is superior to ≥ 25% increase in Cr at identifying patients at greater risk of adverse renal and cardiac events.
